🇨🇦 Dexmetomidine intrathecally in Canada

Dexmetomidine intrathecally (Dexmetomidine intrathecally) regulatory status in Canada.

Marketing authorisation

Dexmetomidine intrathecally in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Dexmetomidine intrathecally approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Dexmetomidine intrathecally in Canada?

KAT General Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.